000			01990 a2200613 4500
005			20250517001822.0
264		0	_c20150728
008			201507s 0 0 eng d
022			_a1791-2431
024	7		_a10.3892/or.2014.3583 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Min-Cong
245	0	0	_aIn vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines. _h[electronic resource]
260			_bOncology reports _cJan 2015
300			_a239-49 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aBase Sequence
650	0	4	_aCarcinoma, Non-Small-Cell Lung
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aCrown Ethers _xpharmacology
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aDrug Synergism
650	0	4	_aErbB Receptors _xgenetics
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aLung Neoplasms
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aResting Phase, Cell Cycle
650	0	4	_aSignal Transduction
700	1		_aLiang, Xuan
700	1		_aLiu, Zhi-Yan
700	1		_aCui, Jie
700	1		_aLiu, Ying
700	1		_aJing, Li
700	1		_aJiang, Li-Li
700	1		_aMa, Jie-Qun
700	1		_aHan, Li-Li
700	1		_aGuo, Qian-Qian
700	1		_aYang, Cheng-Cheng
700	1		_aWang, Jing
700	1		_aWu, Tao
700	1		_aNan, Ke-Jun
700	1		_aYao, Yu
773	0		_tOncology reports _gvol. 33 _gno. 1 _gp. 239-49
856	4	0	_uhttps://doi.org/10.3892/or.2014.3583 _zAvailable from publisher's website
999			_c24329206 _d24329206